Literature DB >> 32737467

A thermostable, closed SARS-CoV-2 spike protein trimer.

Xiaoli Xiong1, Kun Qu2, Katarzyna A Ciazynska2, Myra Hosmillo3, Andrew P Carter2, Soraya Ebrahimi4, Zunlong Ke2, Sjors H W Scheres2, Laura Bergamaschi5, Guinevere L Grice5, Ying Zhang6,7, James A Nathan5, Stephen Baker5, Leo C James8, Helen E Baxendale9, Ian Goodfellow3, Rainer Doffinger4, John A G Briggs10.   

Abstract

The spike (S) protein of SARS-CoV-2 mediates receptor binding and cell entry and is the dominant target of the immune system. It exhibits substantial conformational flexibility. It transitions from closed to open conformations to expose its receptor-binding site and, subsequently, from prefusion to postfusion conformations to mediate fusion of viral and cellular membranes. S-protein derivatives are components of vaccine candidates and diagnostic assays, as well as tools for research into the biology and immunology of SARS-CoV-2. Here we have designed mutations in S that allow the production of thermostable, disulfide-bonded S-protein trimers that are trapped in the closed, prefusion state. Structures of the disulfide-stabilized and non-disulfide-stabilized proteins reveal distinct closed and locked conformations of the S trimer. We demonstrate that the designed, thermostable, closed S trimer can be used in serological assays. This protein has potential applications as a reagent for serology, virology and as an immunogen.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32737467      PMCID: PMC7116388          DOI: 10.1038/s41594-020-0478-5

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  2 in total

1.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

2.  Glycan Shield and Fusion Activation of a Deltacoronavirus Spike Glycoprotein Fine-Tuned for Enteric Infections.

Authors:  Xiaoli Xiong; M Alejandra Tortorici; Joost Snijder; Craig Yoshioka; Alexandra C Walls; Wentao Li; Andrew T McGuire; Félix A Rey; Berend-Jan Bosch; David Veesler
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

  2 in total
  80 in total

Review 1.  Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection.

Authors:  Yu-Chyi Hwang; Ruei-Min Lu; Shih-Chieh Su; Pao-Yin Chiang; Shih-Han Ko; Feng-Yi Ke; Kang-Hao Liang; Tzung-Yang Hsieh; Han-Chung Wu
Journal:  J Biomed Sci       Date:  2022-01-04       Impact factor: 8.410

2.  SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases.

Authors:  Gonzalo Ferreira; Axel Santander; Florencia Savio; Mariana Guirado; Luis Sobrevia; Garth L Nicolson
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-09-03       Impact factor: 5.187

3.  SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity.

Authors:  Annachiara Rosa; Valerie E Pye; Carl Graham; Luke Muir; Jeffrey Seow; Kevin W Ng; Nicola J Cook; Chloe Rees-Spear; Eleanor Parker; Mariana Silva Dos Santos; Carolina Rosadas; Alberto Susana; Hefin Rhys; Andrea Nans; Laura Masino; Chloe Roustan; Evangelos Christodoulou; Rachel Ulferts; Antoni G Wrobel; Charlotte-Eve Short; Michael Fertleman; Rogier W Sanders; Judith Heaney; Moira Spyer; Svend Kjær; Andy Riddell; Michael H Malim; Rupert Beale; James I MacRae; Graham P Taylor; Eleni Nastouli; Marit J van Gils; Peter B Rosenthal; Massimo Pizzato; Myra O McClure; Richard S Tedder; George Kassiotis; Laura E McCoy; Katie J Doores; Peter Cherepanov
Journal:  Sci Adv       Date:  2021-05-28       Impact factor: 14.136

4.  Enhancing the Prefusion Conformational Stability of SARS-CoV-2 Spike Protein Through Structure-Guided Design.

Authors:  Timothy P Riley; Hui-Ting Chou; Ruozhen Hu; Krzysztof P Bzymek; Ana R Correia; Alexander C Partin; Danqing Li; Danyang Gong; Zhulun Wang; Xinchao Yu; Paolo Manzanillo; Fernando Garces
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

5.  SARS-CoV-2 Spike Protein Stabilized in the Closed State Induces Potent Neutralizing Responses.

Authors:  George W Carnell; Katarzyna A Ciazynska; David A Wells; Xiaoli Xiong; Ernest T Aguinam; Stephen H McLaughlin; Donna Mallery; Soraya Ebrahimi; Lourdes Ceron-Gutierrez; Benedikt Asbach; Sebastian Einhauser; Ralf Wagner; Leo C James; Rainer Doffinger; Jonathan L Heeney; John A G Briggs
Journal:  J Virol       Date:  2021-07-12       Impact factor: 5.103

Review 6.  Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy.

Authors:  Qianqian Zhang; Rong Xiang; Shanshan Huo; Yunjiao Zhou; Shibo Jiang; Qiao Wang; Fei Yu
Journal:  Signal Transduct Target Ther       Date:  2021-06-11

7.  Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.

Authors:  Alberto M Borobia; Antonio J Carcas; Mayte Pérez-Olmeda; Luis Castaño; María Jesús Bertran; Javier García-Pérez; Magdalena Campins; Antonio Portolés; María González-Pérez; María Teresa García Morales; Eunate Arana-Arri; Marta Aldea; Francisco Díez-Fuertes; Inmaculada Fuentes; Ana Ascaso; David Lora; Natale Imaz-Ayo; Lourdes E Barón-Mira; Antonia Agustí; Carla Pérez-Ingidua; Agustín Gómez de la Cámara; José Ramón Arribas; Jordi Ochando; José Alcamí; Cristóbal Belda-Iniesta; Jesús Frías
Journal:  Lancet       Date:  2021-06-25       Impact factor: 79.321

8.  Landscape-Based Mutational Sensitivity Cartography and Network Community Analysis of the SARS-CoV-2 Spike Protein Structures: Quantifying Functional Effects of the Circulating D614G Variant.

Authors:  Gennady M Verkhivker; Steve Agajanian; Deniz Yasar Oztas; Grace Gupta
Journal:  ACS Omega       Date:  2021-06-09

9.  Full-Length Computational Model of the SARS-CoV-2 Spike Protein and Its Implications for a Viral Membrane Fusion Mechanism.

Authors:  Wataru Nishima; Marta Kulik
Journal:  Viruses       Date:  2021-06-11       Impact factor: 5.048

Review 10.  SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies.

Authors:  Ahmed M Almehdi; Ghalia Khoder; Aminah S Alchakee; Azizeh T Alsayyid; Nadin H Sarg; Sameh S M Soliman
Journal:  Infection       Date:  2021-08-02       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.